Recall
FDAHealthNovember 19, 2024

Mylan Institutional, Inc. — Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceutic

⚠️ Subpotent and Superpotent Drug

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
November 19, 2024

Nationwide in the USA.

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
Lot code
3115869

Additional details

Lot #: 3115869, Exp. Date 03/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 205 cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.